Drug Profile
Box 5
Alternative Names: Box-5Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator WntResearch
- Class Peptides
- Mechanism of Action Wnt protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Cancer in Sweden (Parenteral)
- 07 Jan 2014 Preclinical development is ongoing in Sweden